BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15657660)

  • 1. Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer.
    Nozawa T; Enomoto T; Koshida Y; Sato Y; Kuranami M
    Dis Colon Rectum; 2004 Dec; 47(12):2093-100. PubMed ID: 15657660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma.
    Saito S; Tsuno N; Nagawa H; Sunami E; Zhengxi J; Osada T; Kitayama J; Shibata Y; Tsuruo T; Muto T
    Cancer; 2000 Jan; 88(1):42-9. PubMed ID: 10618604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas.
    Li C; Shintani S; Terakado N; Klosek SK; Ishikawa T; Nakashiro K; Hamakawa H
    Int J Oral Maxillofac Surg; 2005 Jul; 34(5):559-65. PubMed ID: 16053878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived endothelial cell growth factor expression is an independent prognostic factor in colorectal cancer patients after curative surgery.
    Tsuji T; Sawai T; Yamashita H; Takeshita H; Nakagoe T; Shindou H; Fukuoka H; Yoshinaga M; Hidaka S; Yasutake T; Nagayasu T; Tagawa Y
    Eur J Surg Oncol; 2004 Apr; 30(3):296-302. PubMed ID: 15028312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
    van Triest B; Pinedo HM; Blaauwgeers JL; van Diest PJ; Schoenmakers PS; Voorn DA; Smid K; Hoekman K; Hoitsma HF; Peters GJ
    Clin Cancer Res; 2000 Mar; 6(3):1063-72. PubMed ID: 10741735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease.
    Saito S; Tsuno NH; Sunami E; Hori N; Kitayama J; Kazama S; Okaji Y; Kawai K; Kanazawa T; Watanabe T; Shibata Y; Nagawa H
    J Gastroenterol; 2003; 38(3):229-37. PubMed ID: 12673445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
    Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
    Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of thymidine phosphorylase and its correlation with angiogenesis in gastric adenocarcinoma.
    Ikeguchi M; Oka S; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 1999; 19(5B):4001-5. PubMed ID: 10628344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma.
    Yasuno M; Mori T; Koike M; Takahashi K; Toi M; Takizawa T; Shimizu S; Yamaguchi T; Matsumoto H
    Oncol Rep; 2005 Mar; 13(3):405-12. PubMed ID: 15706408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer.
    Nakamoto RH; Uetake H; Iida S; Kolev YV; Soumaoro LT; Takagi Y; Yasuno M; Sugihara K
    Jpn J Clin Oncol; 2007 Sep; 37(9):679-85. PubMed ID: 17846040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.
    Verbeke H; De Hertogh G; Li S; Vandercappellen J; Noppen S; Schutyser E; El-Asrar AA; Opdenakker G; Van Damme J; Geboes K; Struyf S
    Hum Pathol; 2010 Jul; 41(7):990-1001. PubMed ID: 20334899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between stromal fibroblasts and colorectal cancer cells in the expression of vascular endothelial growth factor.
    Koshida Y; Kuranami M; Watanabe M
    J Surg Res; 2006 Aug; 134(2):270-7. PubMed ID: 16600304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer.
    Tanaka Y; Kobayashi H; Suzuki M; Kanayama N; Suzuki M; Terao T
    Hum Pathol; 2002 Nov; 33(11):1105-13. PubMed ID: 12454815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRL-3 expression in metastatic cancers.
    Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
    Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers.
    O'Brien TS; Fox SB; Dickinson AJ; Turley H; Westwood M; Moghaddam A; Gatter KC; Bicknell R; Harris AL
    Cancer Res; 1996 Oct; 56(20):4799-804. PubMed ID: 8841001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic growth factors in preinvasive breast disease.
    Heffelfinger SC; Miller MA; Yassin R; Gear R
    Clin Cancer Res; 1999 Oct; 5(10):2867-76. PubMed ID: 10537355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.